DEA Regulatory Actions
June 30, 2010 at 20:00:00 ET
DEA Officials Confirm Levmetamfetamine Exclusion In a final rule published March 23, 2010, the Drug Enforcement Administration confirmed that certain over-the-counter nasal decongestant inhaler/vapor inhaler products containing 50 mg levmetamfetamine would continue to be listed as excluded nonnarcotic products (75 FR 13,658). The products had tentatively been grante... Read More
